100 Percent Cancer Remission of Patients in Monoclonal Antibody Trial | Trailer | Facts Matter
šµ Watch the full episode: https://ept.ms/MonoclonalAntibodyRM
According to the results of a recent study, researchers have found a treatment that completely removed the rectal cancer in every patient that participated. Meaning that every single patient in the study is in remissionāand with no chemotherapy, no radiation, and no surgery.
Even though the study was small, the results are not only heartening, but also, according to the lead researcher, they open up a potential new corridor at fighting cancer, which they will be expanding quickly to stomach, pancreatic, and bladder cancer.
Furthermore, the therapy that theyāre testing (monoclonal antibodies) has none of the toxic side-effects of the other treatments for cancer that are currently used at scale.
And so, with all these positive elements lining up, letās go through this study together.
Episode Resources:
šµ Full Study:
https://ept.ms/3J1Iffx
š½No Farmers No Food DVD:
https://www.epochtv.shop/product-page/no-farmers-no-food-documentary-dvd
šŗšøFlash Sale: https://ept.ms/3DkkcWk
āļøSUBSCRIBE to The Epoch Times YouTube channel TODAY:
https://www.youtube.com/channel/UCeLc4heXqG9dtL7jiPHMBfQ?Sub_confirmation=1
š“ Check out ‘The Real Story of January 6’ documentary DVD here: https://ept.ms/3cxGVEO, use promo code āEpochTVā for 20% off!
š“ “The Shadow State,” a feature documentary by The Epoch Times, takes a deep dive inside the environmental, social, and governance (ESG) industry. ORDER DVD: https://ept.ms/3XxcWir
š“ The Final War DVD: https://www.epochtv.shop/product-page/The-Final-War-documentary-dvd
šµ Unlimited #EpochTV access starts at only $1:
https://ept.ms/1DollarNOW
——-
ā Sign up for our NEWSLETTER and stay in touch:
https://ept.ms/EpochTVNewsletter
š Support us to fight for the truth:
https://donorbox.org/epochtv
100 Percent Cancer Remission of Patients in Monoclonal Antibody Trial | Trailer | Facts Matter
#epochtv #cancer #factsmatterwithroman
——————
Ā© All Rights Reserved.